DNA Cell Cycle Analysis by Flow Cytometry
Measurement of DNA ploidy (the amount of DNA material present in cells including tumor cells) and S-Phase Fraction (SPF, the percent of cells actively dividing) provides useful information regarding the biological aggressiveness of malignant tumors. It is used predominantly in the analysis of breast carcinoma as a prognostic test. It has been shown that assessment of DNA ploidy and SPF correlate with tumor size, grade, nodal status, and overall survival. In general, increased SPF and/or aneuploidy (abnormal amount of DNA) are associated with a worse overall outcome. Exceptions include neuroblastoma and acute lymphoblastic leukemia of childhood. Testing can help plan management for patients with limited stage disease. Limitations include the inclusion of non-neoplastic tissue in the sample; hence, selection of malignant cells for analysis is critical for valid results. The inclusion of non-neoplastic tissue may lead to the inability to detect an abnormality.
Normal: Diploid DNA content with a low S-Phase Fraction
Fresh tumor tissue, frozen tumor tissue, formalin fixed paraffin-embedded tissue, adequately cellular body fluid, fine needle aspiration cellular material. Fresh tissue requires immediate processing. Frozen tissue must remain frozen until used for testing. Paraffin-embedded tissue is stable for years.
- Mol Cancer Res. 2011 Sep;9(9):1209-21. [PMID: 21775421]
- Cytometry. 1993; 14(5): 486-91. [PMID: 8354120]
- Cytometry. 1993; 14(5): 492-6. [PMID: 8354121]
- Arch Pathol Lab Med. 2000; 124(7): 966-78. [PMID: 10888772]
- Cytometry. 1993; 14(5): 497-500. [PMID: 8354122]
- Cytometry. 1996 Sep 1;25(1):1-13. [PMID: 8875049]
- Cancer Radiother. 2001 Apr;5(2):109-29. [PMID: 11355576]